Drug-resistant viral hepatitis

J Infect. 2000 Jul;41(1):1-4. doi: 10.1053/jinf.2000.0658.
No abstract available

Publication types

  • Review

MeSH terms

  • Amantadine / therapeutic use
  • Antiviral Agents / therapeutic use
  • Drug Resistance, Microbial
  • Hepacivirus / drug effects*
  • Hepacivirus / genetics
  • Hepatitis B / drug therapy*
  • Hepatitis B Surface Antigens / drug effects
  • Hepatitis B e Antigens / drug effects
  • Hepatitis B virus / drug effects*
  • Hepatitis B virus / genetics
  • Hepatitis C / drug therapy*
  • Humans
  • Interferon-alpha / therapeutic use
  • Lamivudine / therapeutic use
  • Mutation
  • Reverse Transcriptase Inhibitors / therapeutic use
  • Ribavirin / therapeutic use

Substances

  • Antiviral Agents
  • Hepatitis B Surface Antigens
  • Hepatitis B e Antigens
  • Interferon-alpha
  • Reverse Transcriptase Inhibitors
  • Lamivudine
  • Ribavirin
  • Amantadine